Addressing the Challenges of Cold Agglutinin Disease: From Diagnosis to Treatment

Keck School of Medicine of USC
I

CARDINAL Trial 2-Year Follow-Up: Long-Term Sutimlimab for Patients With Cold Agglutinin Disease

By Keck School of Medicine of USC FEATURING Ilene Weitz
By Keck School of Medicine of USC FEATURING Ilene Weitz
159 views
May 23, 2024
Comments 0
Login to view comments. Click here to Login
16:07

Current Management of CAD and the Role of Complement Activation

Shirley D'Sa

47 views
13:52

Diagnosis and Testing Considerations for Cold Agglutinin Disease

Julia Cunningham

175 views
23:57

The Role of Complement in Disease: Focus on PNH, aHUS, CAPS, and CAD

Ilene Weitz

160 views
13:41

CAD: The Basics and Development

Kelly Davidson

358 views
18:39

CAD: The Importance of Treatment Continuity

Sigbjørn Berentsen

70 views
20:56

Sutimlimab in Cold Agglutinin Disease

Kelly Davidson

170 views
10:29

2-Year Results From the CARDINAL Study: Sutimlimab for Complement C1…

Catherine Broome

67 views
22:22

Cold Agglutinin Disease: Pharmacologic Treatment and Clinical Monito…

Irina Murakhovskaya

227 views
07:27

Sutimlimab in Cold Agglutinin Disease: Safety From the Phase 3 Cardi…

Catherine Broome

240 views
34:15

Advances in Hemolytic Anemias: Enzymopathies, Membrane Defects, Auto…

Scripps Health

I. Weitz

560 views
32:32

Refractory Cold Agglutinin Disease Overview and Case Discussion

BMFcases

S. Berentsen, T. Bat

319 views
12:34

Yale ASH Updates on Classical Hematology: PROs of Sutimlimab Use in …

Yale Cancer Center

G. Goshua

347 views